11C-CSar ( DrugBank: - )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
93	Primary biliary cholangitis	1
94	Primary sclerosing cholangitis	1

93. Primary biliary cholangitis

---

Clinical trials : 298 /  Drugs : 252 - (DrugBank : 59) / Drug target genes : 35 - Drug target pathways : 115

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01879735 (ClinicalTrials.gov)	June 2013	11/6/2013	Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT	Hepatic Transport of Conjugated Bile Acids in Humans Quantified by 11C-cholylsarcosine PET/CT	Cholestasis;Primary Sclerosing Cholangitis;Primary Biliary Cirrhosis	Drug: 11C-CSar;Drug: ICG	University of Aarhus	NULL	Completed	18 Years	N/A	All	22	Phase 1	Denmark

94. Primary sclerosing cholangitis

---

Clinical trials : 148 /  Drugs : 118 - (DrugBank : 39) / Drug target genes : 18 - Drug target pathways : 141

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01879735 (ClinicalTrials.gov)	June 2013	11/6/2013	Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT	Hepatic Transport of Conjugated Bile Acids in Humans Quantified by 11C-cholylsarcosine PET/CT	Cholestasis;Primary Sclerosing Cholangitis;Primary Biliary Cirrhosis	Drug: 11C-CSar;Drug: ICG	University of Aarhus	NULL	Completed	18 Years	N/A	All	22	Phase 1	Denmark